BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Alizyme PLC 

280 Cambridge Science Park
Milton Road
Cambridge    CB4 4WE  United Kingdom
Phone: 01223-423070 Fax: 01223-423818


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Alizyme PLC  (AZM.L) Release: Unaudited Preliminary Results For The Year Ended 31 December 2008 3/23/2009 2:54:26 PM
Alizyme PLC  (AZM.L) Announces Headline Results from Its European Phase 3 Clinical Trial 7/24/2008 1:59:41 PM
Alizyme PLC  (AZM.L) Commencement of Phase 2 Study in the U.S. 5/20/2008 12:51:41 PM
Prometheus Laboratories Inc. Licenses COLAL-PRED(R) From Alizyme PLC  (AZM.L) 11/29/2007 8:05:51 AM
Alizyme PLC  (AZM.L) Release: Preliminary Results And Webcast Notification 2/14/2007 1:14:44 PM
UK's Alizyme PLC  (AZM.L) Shares Boosted By Phase 2 Mucositis Drug Data 3/2/2006 10:32:38 AM
Alizyme PLC  (AZM.L) Successful Phase IIb Cetilistat Trial In Obese Diabetics 12/13/2005 3:06:43 PM
Alizyme PLC  (AZM.L) Completes Recruitment For Mucositis Trials, Sees Results Feb 2006 11/22/2005 2:21:00 PM
Alizyme PLC (AZM.L) Obtains Approval For Phase III Clinical Trial Of COLAL-PRED® For The Treatment Of Ulcerative Colitis10/19/2005 5:13:01 PM
Alizyme PLC (AZM.L) The UK Based Speciality Biopharmaceutical Development Company, Today Announces That It Proposes To Raise £32.8 Million10/19/2005 5:11:08 PM
12